Matthews Pacific Tiger Fund Makes 2 New Purchases in 4th Quarter

The Matthews Pacific Tiger Fund (Trades, Portfolio) added two new stakes to its portfolio in the fourth quarter.

The Fund’s most noteworthy fourth-quarter transaction was one of those new buys, Tasly Pharmaceutical Group Co. Ltd. (SHSE:600535, Financial), a Chinese pharmaceutical company in which the Fund acquired an 8,120,247-share stake for an average price of CN¥37.85 (about $5.73 in U.S. currency) per share. The deal had a 0.76% impact on the Fund’s portfolio.

Matthews Pacific Tiger Fund (Trades, Portfolio) is Tasly’s only shareholder among the gurus. The Fund’s stake is 0.75% of Tasly’s outstanding shares and 0.76% of the Fund’s total assets.

Tasly has a P/E of 24.2, a forward P/E of 32.4, a P/B of 5 and a P/S of 2.8. GuruFocus gives Tasly a Financial Strength rating of 7/10 and a Profitability and Growth rating of 8/10.

Tasly Pharmaceutical sold for CN¥32.5 (roughly $4.92 in American dollars) per share Monday.

The Fund’s other new buy was a 10,015,900-share stake in Kasikornbank Public Co. Ltd. (BKK:KBANK, Financial), a Bangkok-based financial institution, for an average price of ฿169.59 (approximately $4.74 in American money) per share. The transaction had a 0.63% impact on the Fund’s portfolio.

Matthews Pacific Tiger Fund (Trades, Portfolio) is Kasikornbank’s only shareholder among the gurus. The Fund’s stake is 0.42% of Kasikornbank’s outstanding shares and 0.63% of the Fund’s total assets.

Kasikornbank has a P/E of 9.2, a forward P/E of 7.6, a P/B of 1.4 and a P/S of 2. GuruFocus gives Kasikornbank a Financial Strength rating of 6/10 and a Profitability and Growth rating of 8/10.

Kasikornbank sold for ฿168 (about $4.69 in U.S. currency) per share Monday.

The Fund reduced its stake in Kasikornbank Public Co. Ltd. (KPCUF, Financial), a Bangkok-based provider of banking products and services, by nearly 74%. The Fund sold 10,015,900 shares for an average price of $6.03 per share. The deal had a -0.76% impact on the Fund’s portfolio.

The Fund is Kasikornbank’s only shareholder among the gurus. Its remaining stake of 3,561,800 shares is 0.15% of Kasikornbank’s outstanding shares and 0.22% of the Fund’s total assets.

Kasikornbank has a P/E of 9.2, a forward P/E of 7.6, a P/B of 1.4 and a P/S of 2. GuruFocus gives Kasikornbank a Financial Strength rating of 6/10 and a Profitability and Growth rating of 8/10..

Kasikornbank sold for $4.08 per share Monday.

The Fund reduced its stake in Green Cross Corp. (XKRX:006280, Financial), a South Korean biopharmaceutical company, by more than 12%. The Fund sold 117,978 shares for an average price of â‚©184,785 (approximately $149.88 in U.S. money) per share. The transaction had a -0.3% impact on the Fund’s portfolio.

The Fund is Green Cross’ only shareholder among the gurus. Its remaining stake of 846,872 shares is 7.33% of Green Cross’ outstanding shares and 1.98% of the Fund’s total assets.

Green Cross has a P/E of 22.1, a forward P/E of 19.3, a P/B of 2.6 and a P/S of 2.7. GuruFocus gives Green Cross a Financial Strength rating of 4/10 and a Profitability and Growth rating of 7/10.

Green Cross sold for â‚©222,500 (roughly $180.47 in American dollars) per share Monday.

The Fund trimmed its stake in AmorePacific Corp. (XKRX:090430), a South Korean cosmetics company, by nearly 11%. The Fund sold 56,329 shares for an average price of â‚©393,985 (about $319.56 in American currency) per share. The deal had a -0.29% impact on the Fund’s portfolio.

The Fund is AmorePacific’s largest shareholder among the gurus. Its stake of 463,182 shares is 0.79% of AmorePacific’s outstanding shares and 2.46% of the Fund’s total assets. Value Partners (Trades, Portfolio) also has shares of AmorePacific in its portfolio.

AmorePacific has a P/E of 45.4, a forward P/E of 36.6, a P/B of 7.3 and a P/S of 6.6. GuruFocus gives AmorePacifi a Financial Strength rating of 10/10 with no debt and a Profitability and Growth rating of 8/10.

AmorePacific sold for â‚©411,500 (approximately $333.77 in U.S. money) per share Monday.

The Fund cut its stake in Hang Lung Group Ltd. (HKSE:00010), a Hong Kong-based property development company, by almost 16%. The Fund sold 4,000,000 shares for an average price of HK$26.79 (roughly $3.43 in U.S. dollars) per share. The transaction had a -0.22% impact on the Fund’s portfolio.

The Fund is Hang Lung’s only shareholder among the gurus. Its 21,553,000-share stake is 1.59% of Hang Lung’s outstanding shares and 1.06% of the Fund’s total assets.

Hang Lung has a P/E of 4.2, a P/B of 0.4 and a P/S of 1.7. GuruFocus gives Hang Lung a Financial Strength rating of 5/10 and a Profitability and Growth rating of 8/10.

Hang Lung sold for HK$20.80 (about $2.67 in American currency) per share Monday.

The Fund reduced its stake in China Resources Beer (Holdings) Co. Ltd. (HKSE:00291), a Chinese investment holding and property investment company, by nearly 13%. The Fund sold 6,500,000 shares for an average price of HK$14.91 (roughly $1.92 in American money) per share. The transaction had a -0.19% impact on the Fund’s portfolio.

The Fund is China Resources Beer’s only shareholder among the gurus. Its 43,802,000-share stake is 1.81% of the company’s outstanding shares and 1.41% of the Fund’s total assets.

China Resources Beer has a forward P/E of 16.3, a P/B of 0.7 and a P/S of 0.2. GuruFocus gives China Resources Beer a Financial Strength rating of 5/10 and a Profitability and Growth rating of 6/10.

China Resources Beer sold for HK$12.66 (about $1.63 in U.S. dollars) per share Monday.

The Fund reduced its stake in Astra International Tbk. (ISX:ASII), an Indonesian conglomerate, by almost 17%. The Fund sold 27,000,000 shares for an average price of IDR 6,234.23 (approximately 44 cents in U.S. currency) per share. The deal had a -0.16% impact on the Fund’s portfolio.

The Fund is Astra International’s only shareholder among the gurus with a stake of 132,745,900 shares. The stake is 0.33% of Astra International’s outstanding shares and 0.86% of the Fund’s total assets.

Astra International has a P/E of 21.7, a P/B of 2.6 and a P/S of 1.9. GuruFocus gives Astra International a Financial Strength rating of 4/10 and a Profitability and Growth rating of 7/10.

Astra International sold for IDR 6,350 (roughly 45 cents in American money) per share Monday.

The Fund sold its 2,220,199-share stake in Shanghai Jahwa United Co Ltd. (SHSE:600315), a Chinese personal chemical products company, for an average price of CN¥38.09 (approximately $5.77 in U.S. money) per share. The deal had a -0.19% impact on the Fund’s portfolio.

Shanghai Jahwa United has a P/E of 21.2, a forward P/E of 27, a P/B of 4.7 and a P/S of 3.5. GuruFocus gives Shanghai Jahwa United a Financial Strength rating of 10/10 with no debt and a Profitability and Growth rating of 8/10.

Shanghai Jahwa United sold for CN¥30.5 (roughly $4.62 in American dollars) per share Monday.

The Fund raised its stake in Inner Mongolia Yili Industrial Group Co. Ltd. (SHSE:600887), a Chinese dairy company, by almost 17%. The Fund purchased 3,999,992 shares for an average price of CN¥15.75 (about $2.38 in American currency) per share. The deal had a 0.15% impact on the Fund’s portfolio.

The Fund is Inner Mongolia Yili’s only shareholder among the gurus. Its stake of 28,190,596 shares is 0.46% of the company’s outstanding shares and 1.06% of the Fund’s total assets.

Inner Mongolia Yili has a P/E of 19.5, a forward P/E of 21.3, a P/B of 4.2 and a P/S of 1.4. GuruFocus gives Inner Mongolia Yili a Financial Strength rating of 7/10 and a Profitability and Growth rating of 7/10.

Inner Mongolia Yili sold for CN¥13.23 (approximately $2.00 in U.S. money) per share Monday.

To view the portfolios of more gurus, visit the List of Gurus page. Not a premium member of GuruFocus? Try it free for 7 days.